首页 正文

Intratumoral immunotherapy prior to cancer surgery, a promising therapeutic approach

{{output}}
Cancer immunotherapy has made astonishing progress in the last 10-15 years, and the rate of progress is accelerating. However, only 20 to 40% of patients benefit from this therapy with most immunotherapy applied post discovery of metastatic disease when therap... ...